Total Payments
$6,406
2024 Payments
$2,413
Companies
29
Transactions
404
Medicare Patients
1,644
Medicare Billing
$126,250
Payment Breakdown by Category
Food & Beverage$5,610 (87.6%)
Travel$795.86 (12.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,610 | 401 | 87.6% |
| Travel and Lodging | $795.86 | 3 | 12.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,289 | 191 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,146 | 90 | $0 (2024) |
| Boston Scientific Corporation | $1,056 | 6 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $276.55 | 16 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $242.10 | 16 | $0 (2024) |
| Ardelyx, Inc. | $218.93 | 15 | $0 (2024) |
| Janssen Biotech, Inc. | $167.91 | 10 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $152.92 | 9 | $0 (2024) |
| Gilead Sciences, Inc. | $108.03 | 6 | $0 (2024) |
| PFIZER INC. | $101.86 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,413 | 110 | Boston Scientific Corporation ($1,056) |
| 2023 | $1,652 | 127 | ABBVIE INC. ($667.92) |
| 2022 | $983.05 | 72 | ABBVIE INC. ($425.93) |
| 2021 | $1,358 | 95 | AbbVie Inc. ($499.25) |
All Payment Transactions
404 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $7.66 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/09/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $13.98 | General |
| Category: GI | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $10.14 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/02/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Gastroenterology | ||||||
| 11/22/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: LIVER DISEASE | ||||||
| 11/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Immunology | ||||||
| 11/06/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/04/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/01/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $9.34 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Gastroenterology | ||||||
| 10/30/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $9.14 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: LIVER DISEASE | ||||||
| 10/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $6.39 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $4.45 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.34 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Gastroenterology | ||||||
| 09/18/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: VIROLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $4.74 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 467 | 546 | $222,750 | $36,148 |
| 2022 | 4 | 506 | 611 | $258,854 | $46,001 |
| 2021 | 6 | 322 | 350 | $93,376 | $24,243 |
| 2020 | 7 | 349 | 393 | $65,076 | $19,857 |
Total Patients
1,644
Total Services
1,900
Medicare Billing
$126,250
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 154 | 177 | $79,650 | $13,217 | 16.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 196 | 252 | $81,900 | $12,707 | 15.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 99 | 99 | $54,450 | $8,986 | 16.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $6,750 | $1,237 | 18.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 178 | 232 | $104,563 | $18,531 | 17.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 127 | 127 | $70,516 | $12,786 | 18.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 169 | 220 | $71,725 | $12,571 | 17.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 32 | 32 | $12,050 | $2,113 | 17.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 94 | 108 | $30,406 | $8,852 | 29.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 56 | 56 | $27,898 | $6,055 | 21.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 86 | 97 | $17,748 | $5,380 | 30.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 53 | 56 | $8,064 | $1,795 | 22.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 20 | 20 | $6,556 | $1,391 | 21.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 13 | 13 | $2,704 | $770.07 | 28.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 124 | 148 | $21,128 | $7,052 | 33.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 93 | 103 | $21,115 | $5,635 | 26.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 55 | 63 | $8,757 | $2,513 | 28.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 25 | 26 | $5,408 | $1,854 | 34.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 12 | 12 | $3,792 | $1,237 | 32.6% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 29 | 30 | $2,610 | $880.80 | 33.7% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 11 | 11 | $2,266 | $685.29 | 30.2% |
About Brittany Davidson, APRN
Brittany Davidson, APRN is a Family healthcare provider based in Owensboro, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2016. The National Provider Identifier (NPI) number assigned to this provider is 1043754815.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brittany Davidson, APRN has received a total of $6,406 in payments from pharmaceutical and medical device companies, with $2,413 received in 2024. These payments were reported across 404 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($5,610).
As a Medicare-enrolled provider, Davidson has provided services to 1,644 Medicare beneficiaries, totaling 1,900 services with total Medicare billing of $126,250. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Owensboro, KY
- Active Since 12/13/2016
- Last Updated 12/28/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1043754815
Products in Payments
- ORBERA Intragastric Balloon System (Device) $1,056
- XIFAXAN (Drug) $865.01
- RINVOQ (Biological) $699.02
- CREON (Drug) $583.48
- HUMIRA (Biological) $341.03
- TRULANCE (Drug) $281.00
- SKYRIZI (Biological) $248.43
- Linzess (Drug) $242.10
- IBSRELA (Drug) $218.93
- LINZESS (Drug) $153.62
- OCALIVA (Drug) $152.92
- VIBERZI (Drug) $131.72
- MAVYRET (Drug) $131.66
- ENTYVIO (Biological) $114.95
- GATTEX (Drug) $109.79
- XELJANZ (Drug) $101.86
- STELARA (Biological) $87.64
- ZENPEP (Drug) $80.96
- DIFICID (Drug) $61.46
- AMJEVITA (Biological) $47.80
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Owensboro
Dr. Sara Doolin-Thompson, Dnp, Aprn-Bc, Cnor, DNP, APRN-BC, CNOR
Family — Payments: $29,024
Family $29,024
Mrs. Melanie Mccarty, Aprn, APRN
Family — Payments: $11,216
Family $11,216
Sylvia Sweatt, Aprn, APRN
Family — Payments: $8,306
Family $8,306
Brian Payne, Arnp, ARNP
Family — Payments: $8,017
Family $8,017
Tasia Thompson, Aprn, APRN
Family — Payments: $7,729
Family $7,729
Kelsey Pedley, Aprn, APRN
Family — Payments: $7,601
Family $7,601